Přehled o publikaci
2024
Variants of NAV3, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly
GHAFFAR, Amama, Tehmeena AKHTER, Petter STROMME, Doriana MISCEO, Amjad KHAN et. al.Basic information
Original name
Variants of NAV3, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly
Authors
GHAFFAR, Amama, Tehmeena AKHTER, Petter STROMME, Doriana MISCEO, Amjad KHAN, Eirik FRENGEN, Muhammad UMAIR, Bertrand ISIDOR, Benjamin COGNE, Asma A KHAN, Ange-Line BRUEL, Arthur SORLIN, Paul KUENTZ, Christine CHIAVERINI, A Micheil INNES, Michael ZECH, Marek BALÁŽ, Petra HAVRANKOVA, Robert JECH, Zubair M AHMED, Sheikh RIAZUDDIN and Saima RIAZUDDIN
Edition
Communications Biology, BERLIN, Nature Research, 2024, 2399-3642
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Germany
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001265543500001
EID Scopus
2-s2.0-85197708502
Keywords in English
NAV3
Links
LX22NPO5107, research and development project.
Changed: 6/2/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
Microtubule associated proteins (MAPs) are widely expressed in the central nervous system, and have established roles in cell proliferation, myelination, neurite formation, axon specification, outgrowth, dendrite, and synapse formation. We report eleven individuals from seven families harboring predicted pathogenic biallelic, de novo, and heterozygous variants in the NAV3 gene, which encodes the microtubule positive tip protein neuron navigator 3 (NAV3). All affected individuals have intellectual disability (ID), microcephaly, skeletal deformities, ocular anomalies, and behavioral issues. In mouse brain, Nav3 is expressed throughout the nervous system, with more prominent signatures in postmitotic, excitatory, inhibiting, and sensory neurons. When overexpressed in HEK293T and COS7 cells, pathogenic variants impaired NAV3 ability to stabilize microtubules. Further, knocking-down nav3 in zebrafish led to severe morphological defects, microcephaly, impaired neuronal growth, and behavioral impairment, which were rescued with co-injection of WT NAV3 mRNA and not by transcripts encoding the pathogenic variants. Our findings establish the role of NAV3 in neurodevelopmental disorders, and reveal its involvement in neuronal morphogenesis, and neuromuscular responses.